National Comprehensive Cancer Network Announces New Journal
ROCKLEDGE, PA, February 3, 2003 - The National Comprehensive Cancer Network (NCCN), an alliance of nineteen of the world’s leading cancer centers, proudly introduces the inaugural issue of The Journal of the National Comprehensive Cancer Network (JNCCN). JNCCN is published for the NCCN by Jones and Bartlett Publishers. A quarterly publication, JNCCN is one of the most widely circulated peer-reviewed journals in oncology.
JNCCN focuses on communicating the NCCN Clinical Practice Guidelines in Oncology and provides analysis and exposition of issues highlighted by the Guideline recommendations as they relate to the delivery of effective, efficient, and high quality cancer care. NCCN guidelines are widely recognized and used as the standard for clinical policy in oncology. The journal also will feature analyses from the NCCN Oncology Outcomes Database and other national databases as well as articles, research findings, and commentaries across the broad spectrum of oncology practice.
“The NCCN is responding to the call to improve communication and enhance collaboration between academic and community oncologists. JNCCN will serve as an important forum for the presentation of the NCCN guidelines and for discussion of issues that arise from their use by physicians, patients, managed care companies, and policymakers, as well as other groups,” said William T. McGivney, Ph.D., Chief Executive Officer of the NCCN.
The first issue presents NCCN’s colorectal treatment, colorectal screening, gastric, esophageal, and hepatobiliary guidelines with supporting review articles. Subsequent 2003 issues will discuss breast cancer, supportive care, and hematologic malignancies. Each issue will also include a profile of an NCCN member institution; the premiere issue features City of Hope Cancer Center of Los Angeles.
“As a founding member of this important organization, City of Hope greatly values its alliance with the NCCN and its members,” said Theodore G. Krontiris, MD, PhD, Executive Vice President for Medical & Scientific Affairs at City of Hope and Director of City of Hope’s Comprehensive Cancer Center. “ We are pleased to participate in the development of disease guidelines that will benefit those receiving care today and in years to come.”
“We fully expect JNCCN to become the most widely-read journal in the oncology community. Jones and Bartlett is proud to collaborate with the NCCN in the establishment of this most credible source of evaluative information,” said Christopher Davis, Executive Publisher of Jones and Bartlett Publishers.
“NCCN expert clinicians volunteer and dedicate themselves to distilling the best scientific information available into guidelines that lay out the clinical decision making process,” said Rodger J. Winn, MD, Editor-in-Chief of JNCCN. “JNCCN addresses issues that medical oncologists, surgeons, and radiation oncologists face in their everyday practice in dealing with the many parties that seek to influence practice. In the end, the goal of the NCCN is to enhance the effectiveness and efficiency of care delivery to the patients whom we serve.”
JNCCN will complement and extend NCCN programs in practice guidelines, patient information, outcomes data, clinical trials, and specialty oncology networks. The journal will build upon the NCCN’s success in meeting the information needs of decision-makers in these areas along the continuum of cancer care.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
- City of Hope Comprehensive Cancer Center
- Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
- Duke Cancer Institute
- Fox Chase Cancer Center
- Huntsman Cancer Institute at the University of Utah
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Mayo Clinic Cancer Center
- Memorial Sloan Kettering Cancer Center
- Moffitt Cancer Center
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- Roswell Park Cancer Institute
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
- Stanford Cancer Institute
- University of Alabama at Birmingham Comprehensive Cancer Center
- UC San Diego Moores Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
- University of Colorado Cancer Center
- University of Michigan Comprehensive Cancer Center
- The University of Texas MD Anderson Cancer Center
- University of Wisconsin Carbone Cancer Center
- Vanderbilt-Ingram Cancer Center
- Yale Cancer Center/Smilow Cancer Hospital